The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.

The International Society for Stem Cell Research (ISSCR) voices concern as the Italian government authorizes an unproven stem cell therapy for use in patients.

The ISSCR congratulates its current president, Shinya Yamanaka, board member Hans Clevers and the ISSCR 11th Annual Meeting Keynote Speaker, Eric Lander, recipients of the inaugural Breakthrough Prize in Life Sciences.

With more than 2000 abstracts having been received, we have set a new record for submissions for the Annual Meeting! Thank you to all who sent in their abstracts, and we look forward to seeing you in Boston this June!